UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K

                                 CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported):     April 29, 1998

                           Lukens Medical Corporation
                           --------------------------
             (Exact name of registrant as specified in its charter)

   Delaware                         1-11109                 22-2429965
   --------                         -------                 ----------
(State or other                 (Commission File         (I.R.S. Employer
jurisdiction of                 Number)                  Identification
incorporation)                                           Number)

3820 Academy Parkway North, NE, Albuquerque, New Mexico           87109
-------------------------------------------------------           -----
     (Address of principal executive offices)                     (Zip Code)

Registrant's telephone number, including area code:    (505) 342-9638
                                                       -------------




          -------------------------------------------------------------
          (Former name or former address, if changed since last report)




                  Exhibit Index on Sequentially Numbered Page 4


<PAGE>



                      INFORMATION TO BE INCLUDED IN REPORT


Item 5.  Other Events.

     On April 29,  1998,  the  Registrant  announced  that on April 28,  1998 it
entered  into an  Agreement  and Plan of Merger  with  London-based  Medisys PLC
("Medisys"),  pursuant to which Medisys would  acquire the  Registrant,  and the
stockholders  of the Registrant  would receive $4.00, in cash, for each share of
Common Stock of the Registrant.  The  consummation of the merger is subject to a
number of conditions, including without limitation, approval by the stockholders
of the  Registrant,  satisfactory  completion  of due  diligence and securing of
financing by Medisys  sufficient to consummate  the merger and the  transactions
contemplated thereby. The merger is expected to close this summer.

     Medisys  also  recently  purchased  75,000  shares of Common Stock from the
Registrant  for  $4.00  per  share  in cash in  private  transactions  with  the
Registrant.

     As part of the Merger  Agreement,  the outside  directors of the Registrant
agreed to vote their shares in favor of the Merger at the special  meeting to be
called to approve the  transaction.  These outside  directors  collectively  own
approximately  29% of the outstanding  shares of Common Stock of the Registrant.
Additionally, in connection with the Merger, Medisys has agreed to repay certain
outstanding  loans due from the  Company to two of its outside  directors  in an
aggregate  principal  amount  equal to $2.3  million  (plus  accrued  but unpaid
interest), by payment of cash and $1.0 million worth of Medisys ordinary shares.
In the event of a termination of the Merger Agreement  directly or indirectly as
a result of an alternative  acquisition proposal being made, or the Registrant's
failure to obtain stockholder approval,  the Registrant may be required to pay a
break-up fee to Medisys in the amount of $500,000.

Item 7. Financial Statements and Exhibits

          (c)  Exhibits

               2.1  Agreement  and Plan of Merger,  dated as of April 28,  1998,
                    among Medisys PLC, LMC Acquisition  Corp. and Lukens Medical
                    Corporation



                                        2

<PAGE>



                                   SIGNATURES


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  Report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                             LUKENS MEDICAL CORPORATION
                                                     (Registrant)


                                             By:   /s/ Robert S. Huffstodt
                                                --------------------------------
                                                  Robert S. Huffstodt, President
                                                  and Chief Executive Officer





Dated:   May 1, 1998




                                        3

<PAGE>



                                  EXHIBIT INDEX



                                                                    Sequentially
         Exhibit                                                   Numbered Page
         -------                                                   -------------

2.1  Agreement  and Plan of Merger,  dated as of April 28, 1998,         5
     among Medisys PLC, LMC Acquisition Corp. and Lukens Medical
     Corporation





                                4
[{"type": "8-K", "sequence": "1", "description": "FORM 8-K", "secsgml_size_bytes": 4999}]
{"company-data": {"conformed-name": "LUKENS MEDICAL CORP", "cik": "0000857802", "assigned-sic": "3841", "irs-number": "222429965", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-11109", "film-number": "98610679"}, "business-address": {"street1": "3820 ACADEMY PKWY N NE", "city": "ALBUQERQUE", "state": "NM", "zip": "87109", "phone": "5058924118"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):     April 29, 1998

                           Lukens Medical Corporation
                           --------------------------
             (Exact name of registrant as specified in its charter)

   Delaware                         1-11109                 22-2429965
   --------                         -------                 ----------
(State or other                 (Commission File         (I.R.S. Employer
jurisdiction of                 Number)                  Identification
incorporation)                                           Number)

3820 Academy Parkway North, NE, Albuquerque, New Mexico           87109
-------------------------------------------------------           -----
     (Address of principal executive offices)                     (Zip Code)

Registrant's telephone number, including area code:    (505) 342-9638
                                                       -------------

          -------------------------------------------------------------
          (Former name or former address, if changed since last report)

                  Exhibit Index on Sequentially Numbered Page 4
INFORMATION TO BE INCLUDED IN REPORT

Item 5.  Other Events.

     On April 29,  1998,  the  Registrant  announced  that on April 28,  1998 it
entered  into an  Agreement  and Plan of Merger  with  London-based  Medisys PLC
("Medisys"),  pursuant to which Medisys would  acquire the  Registrant,  and the
stockholders  of the Registrant  would receive $4.00, in cash, for each share of
Common Stock of the Registrant.  The  consummation of the merger is subject to a
number of conditions, including without limitation, approval by the stockholders
of the  Registrant,  satisfactory  completion  of due  diligence and securing of
financing by Medisys  sufficient to consummate  the merger and the  transactions
contemplated thereby. The merger is expected to close this summer.

     Medisys  also  recently  purchased  75,000  shares of Common Stock from the
Registrant  for  $4.00  per  share  in cash in  private  transactions  with  the
Registrant.

     As part of the Merger  Agreement,  the outside  directors of the Registrant
agreed to vote their shares in favor of the Merger at the special  meeting to be
called to approve the  transaction.  These outside  directors  collectively  own
approximately  29% of the outstanding  shares of Common Stock of the Registrant.
Additionally, in connection with the Merger, Medisys has agreed to repay certain
outstanding  loans due from the  Company to two of its outside  directors  in an
aggregate  principal  amount  equal to $2.3  million  (plus  accrued  but unpaid
interest), by payment of cash and $1.0 million worth of Medisys ordinary shares.
In the event of a termination of the Merger Agreement  directly or indirectly as
a result of an alternative  acquisition proposal being made, or the Registrant's
failure to obtain stockholder approval,  the Registrant may be required to pay a
break-up fee to Medisys in the amount of $500,000.

Item 7. Financial Statements and Exhibits

          (c)  Exhibits

               2.1  Agreement  and Plan of Merger,  dated as of April 28,  1998,
                    among Medisys PLC, LMC Acquisition  Corp. and Lukens Medical
                    Corporation

                                        2
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  Report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                             LUKENS MEDICAL CORPORATION
                                                     (Registrant)

                                             By:   /s/ Robert S. Huffstodt
                                                --------------------------------
                                                  Robert S. Huffstodt, President
                                                  and Chief Executive Officer

Dated:   May 1, 1998

                                        3
EXHIBIT INDEX

                                                                    Sequentially
         Exhibit                                                   Numbered Page
         -------                                                   -------------

2.1  Agreement  and Plan of Merger,  dated as of April 28, 1998,         5
     among Medisys PLC, LMC Acquisition Corp. and Lukens Medical
     Corporation

                                4